| Identification | Back Directory | [Name]
2-[2-(4-Bromophenyl)-1H-benzimidazol-6-yl]-2,3-dihydro-5-(4-morpholinyl)-1H-isoindol-1-one | [CAS]
2376876-87-6 | [Synonyms]
2-[2-(4-Bromophenyl)-1H-benzimidazol-6-yl]-2,3-dihydro-5-(4-morpholinyl)-1H-isoindol-1-one | [Molecular Formula]
C25H21BrN4O2 | [MOL File]
2376876-87-6.mol | [Molecular Weight]
489.36 |
| Chemical Properties | Back Directory | [Boiling point ]
754.2±70.0 °C(Predicted) | [density ]
1.525±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | [solubility ]
Soluble to 10 mM in DMSO | [pka]
10.31±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
CDK-IN-11 is a heterocyclic compound that has an action of promoting cardiomyocyte maturation[1]. | [Biological Activity]
T 112 is an estrogen-related receptor gamma (ERRγ) agonist. Promotes maturation of hiPSC-derived cardiomyocytes. T 112 accelerates metabolic and sarcomere maturation in cardiomyocytes, as well as maturation of contractile and electrophysiological properties and ultrastructure organization, when used alone or in combination with other small molecules. | [storage]
Store at -20°C | [References]
[1] Yoshida S, et al. Heterocyclic compound. Japan, JPWO2019189553A1. 2021-03-25. |
|
| Company Name: |
R&D Systems, Inc
|
| Tel: |
18003437475 18003437475 |
| Website: |
www.rndsystems.com |
|